Financhill
Sell
1

NTLA Quote, Financials, Valuation and Earnings

Last price:
$10.18
Seasonality move :
-8.17%
Day range:
$9.93 - $11.43
52-week range:
$9.93 - $34.87
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
22.72x
P/B ratio:
1.08x
Volume:
7.2M
Avg. volume:
2.5M
1-year change:
-64.68%
Market cap:
$1B
Revenue:
$36.3M
EPS (TTM):
-$5.44

Earnings Data

Next earnings date for NTLA
Feb 21
2025
Most recent earnings per share
-$1.34
Beat by $0.03
(Nov 7/2024)
Consensus Estimate
-$1.37
(Nov 7/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

NTLA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 $10.3M -- -- -$1.37 --
02/21/2025 Q4 $9.3M -- -- -$1.32 --
11/07/2024 Q3 $7.5M $9.1M -$1.34 -$1.37 $0.03
08/08/2024 Q2 $18.5M $7M -$1.52 -$1.20 -$0.32
05/09/2024 Q1 $9.1M $28.9M -$1.12 -$1.36 $0.24
02/22/2024 Q4 $11.4M -$1.9M -$1.46 -$1.44 -$0.02
11/09/2023 Q3 -- -- -$1.38 -$1.50 $0.12
08/03/2023 Q2 -- -- -$1.40 -$1.33 -$0.07
05/04/2023 Q1 -- -- -$1.17 -$1.38 $0.21
02/23/2023 Q4 -- -- -$1.40 -$1.37 -$0.03
11/03/2022 Q3 -- -- -$1.49 -$1.25 -$0.24
08/04/2022 Q2 -- -- -$1.33 -$1.30 -$0.03
05/05/2022 Q1 -- -- -$1.96 -$1.11 -$0.85
02/24/2022 Q4 -- -- -$1.09 -$0.94 -$0.15
11/04/2021 Q3 -- -- -$0.97 -$0.85 -$0.12
08/05/2021 Q2 -- -- -$1.01 -$0.61 -$0.40
05/06/2021 Q1 -- -- -$0.69 -$0.66 -$0.03
02/25/2021 Q4 -- -- -$0.69 -$0.61 -$0.08
11/05/2020 Q3 -- -- -$0.47 -$0.57 $0.10
08/06/2020 Q2 -- -- -$0.61 -$0.67 $0.06
05/07/2020 Q1 -- -- -$0.63 -$0.47 -$0.16
02/27/2020 Q4 -- -- -$0.58 -$0.56 -$0.02
10/31/2019 Q3 -- -- -$0.49 -$0.61 $0.12
08/01/2019 Q2 -- -- -$0.56 -$0.59 $0.03
05/02/2019 Q1 -- -- -$0.49 -$0.57 $0.08
02/27/2019 Q4 -- -- -$0.43 -$0.54 $0.11
10/31/2018 Q3 -- -- -$0.53 -$0.49 -$0.04
08/01/2018 Q2 -- -- -$0.52 -$0.56 $0.04
05/01/2018 Q1 -- -- -$0.51 -$0.56 $0.05
03/14/2018 Q4 -- -- -$0.61 -$0.45 -$0.16
10/31/2017 Q3 -- -- -$0.44 -$0.50 $0.06
06/30/2017 Q2 -- -- -$0.45 -$0.42 -$0.03
03/31/2017 Q1 -- -- -$0.36 -$0.35 -$0.01

Intellia Therapeutics Earnings Questions

  • How Much did Intellia Therapeutics Generate in Revenue Last Quarter?

    Intellia Therapeutics reported $9.1M worth of top line sales in its most recent quarter.

  • Did Intellia Therapeutics Beat Earnings Last Quarter?

    Intellia Therapeutics announced earnings per share of -$1.34 which represents a beat of analyst forecast a -$1.37 per share.

  • Is Intellia Therapeutics Profitable?

    Intellia Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Intellia Therapeutics EPS Next Year?

    Intellia Therapeutics's earnings are forecast to decrease from -$5.42 per share to -$5.27 per share next year representing a decrease of -3.84%.

  • When is Intellia Therapeutics's Earnings Date?

    Intellia Therapeutics's next earnings date is February 21, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

4 Top Dividend Stocks to Buy Now
4 Top Dividend Stocks to Buy Now

If you’re looking for steady income, dividend stocks are a…

Will Uber Stock Recover?
Will Uber Stock Recover?

Shares of Uber Technologies (NYSE:UBER) have had a rough few…

Is ARK Next Generation Internet ETF a Good Investment?
Is ARK Next Generation Internet ETF a Good Investment?

The ARK Next Generation Internet ETF looks like a pretty…

Stock Ideas

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 39x

Sell
47
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 114x

Sell
39
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 36x

Alerts

Buy
87
CEG alert for Jan 11

Constellation Energy [CEG] is up 25.15% over the past day.

Sell
1
MCY alert for Jan 11

Mercury General [MCY] is down 19.87% over the past day.

Buy
84
ATZAF alert for Jan 11

Aritzia [ATZAF] is up 17.63% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock